TY  - GEN
AU  - Hu,Hongxiang
AU  - Lin,Zhiqiang
AU  - He,Bing
AU  - Dai,Wenbing
AU  - Wang,Xueqing
AU  - Wang,Jiancheng
AU  - Zhang,Xuan
AU  - Zhang,Hua
AU  - Zhang,Qiang
TI  - A novel localized co-delivery system with lapatinib microparticles and paclitaxel nanoparticles in a peritumorally injectable in situ hydrogel
SN  - 1873-4995
PY  - 2017///0110
KW  - ATP Binding Cassette Transporter, Subfamily B
KW  - antagonists & inhibitors
KW  - Administration, Oral
KW  - Animals
KW  - Antineoplastic Agents, Phytogenic
KW  - administration & dosage
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Cell Survival
KW  - drug effects
KW  - Delayed-Action Preparations
KW  - Dose-Response Relationship, Drug
KW  - Drug Carriers
KW  - Drug Combinations
KW  - Drug Compounding
KW  - Drug Synergism
KW  - Female
KW  - G2 Phase Cell Cycle Checkpoints
KW  - Humans
KW  - Hydrogels
KW  - Injections, Intralesional
KW  - Injections, Intravenous
KW  - Lapatinib
KW  - MCF-7 Cells
KW  - Mice, Inbred BALB C
KW  - Mice, Nude
KW  - Nanoparticles
KW  - Nanotechnology
KW  - Paclitaxel
KW  - Poloxamer
KW  - chemistry
KW  - Protein Kinase Inhibitors
KW  - Quinazolines
KW  - Receptor, ErbB-2
KW  - Solubility
KW  - Technology, Pharmaceutical
KW  - methods
KW  - Temperature
KW  - Time Factors
KW  - Tumor Burden
KW  - Xenograft Model Antitumor Assays
N1  - Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.jconrel.2015.10.018
ER  -